Syncope, a temporary loss of consciousness due to inadequate cerebral blood flow, presents a diagnostic challenge in clinical practice. It accounts for approximately 1% of hospital admissions, necessitating a comprehensive approach for effective diagnosis and management.
Initial evaluation should include a detailed history and physical examination, focusing on pre-syncopal symptoms, triggers, and recovery period. Orthostatic blood pressure measurements and electrocardiogram (ECG) are essential in identifying underlying cardiac conditions. Further, risk stratification tools like the San Francisco Syncope Rule and the Canadian Syncope Risk Score can guide decision-making.
When initial evaluation is inconclusive, further diagnostic modalities may be employed. Carotid sinus massage can reveal carotid sinus hypersensitivity, while tilt-table testing can diagnose neurocardiogenic syncope. Ambulatory ECG monitoring is useful in detecting intermittent arrhythmias. Advanced imaging techniques like echocardiography or cardiac MRI can identify structural heart disease.
Treatment should be tailored according to the underlying cause and patient's risk profile. Non-pharmacological interventions, such as lifestyle modifications and physical counterpressure manoeuvres, are often first-line. Pharmacological treatment options include beta-blockers, fludrocortisone, and midodrine. In refractory cases or high-risk patients, cardiac pacing or implantable cardioverter-defibrillators may be necessary.
Managing syncope in clinical practice requires a meticulous approach, beginning with a thorough history and physical examination, followed by appropriate diagnostic testing. Treatment strategies should be individualized, considering the underlying cause and patient's risk profile. By adopting a comprehensive approach, clinicians can effectively diagnose and manage this common, yet often perplexing, clinical entity.
1.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
2.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
3.
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
4.
Biocomputer From Human Neurons Plays Doom, Raises Ethics
5.
AI is useful in low-resource areas for triaging breast masses.
1.
Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers
2.
Clinical Perspectives in Oncology for Better Care
3.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
4.
Emerging Therapies Using Immune-Engineered Cancer Eradication Platforms
5.
Radiomics-Based Prediction of Treatment Response in Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Innovations in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation